{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T02:59:32Z","timestamp":1701831572659},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Systemic lupus erythematosus is a rare autoimmune disorder, with the prevalence in Asia ranging from 30 to 50\/100,000. The diagnosis of systemic lupus erythematosus is made according to the 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria, and it does not contain lymphadenopathy as diagnostic criteria. However, lupus lymphadenopathy has an estimated prevalence of 5\u20137% at the onset of disease, and 12\u201315% at any stage of the disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 19-year-old Sinhalese girl had neck nodules since the age of 5\u00a0years, which increased in size and became tender since 1\u00a0year. She had alopecia and joint stiffness for 6\u00a0months. She presented with a 5-day history of worsening joint pain, fever, and painful, enlarging cervical nodules. She had tender cervical lymphadenopathy, and a vasculitic rash on both lower limbs. She had pancytopenia, an erythrocyte sedimentation rate of 92, positive antinuclear antibody titer, and high anti-double-stranded deoxyribonucleic acid (DNA), with low C3 and C4 complements. She had a high reticulocyte count of 5%, with direct and indirect antiglobulin tests being positive, indicating autoimmune hemolytic anemia. Lymph node biopsy showed moderate reactive follicular hyperplasia, with scattered plasma cells and immunoblasts, with varying degree of coagulative necrosis, suggestive of lupus lymphadenopathy. On immunohistochemistry of the lymph node biopsy, Bcl2 was negative, excluding lymphoma. Contrast-enhanced computed tomography of abdomen and chest was normal with no hepatosplenomegaly or lymphadenopathy. Skin biopsy showed leukocytoclastic vasculitis. Later, with development of generalized edema, she was found to have impaired renal function, and renal biopsy showed lupus nephritis. She was started on hydroxychloroquine, prednisolone, and mycophenolate mofetil, and her symptoms improved and lymphadenopathy regressed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In the case of cervical lymphadenopathy in a patient with systemic lupus erythematosus, the possibilities of lupus lymphadenopathy, Kikuchi\u2013Fujimoto disease, and lymphoma should all be considered, after excluding secondary infection due to immunosuppression. Histology confirms the differentiation of these pathologies. It is important to differentiate the cause for lymphadenopathy in systemic lupus erythematosus as the outcome and treatment varies. Lupus lymphadenopathy is usually generalized, but isolated cervical lymphadenopathy could also rarely be the first presentation of systemic lupus erythematosus. Lupus lymphadenopathy can be the only presenting feature, and needs a high index in suspecting systemic lupus erythematosus, though it is not included in the diagnostic criteria.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-021-02949-5","type":"journal-article","created":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T23:03:07Z","timestamp":1624834987000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A young girl with chronic isolated cervical lymphadenopathy found to have lupus lymphadenopathy, progressing to develop lupus nephritis: a case report"],"prefix":"10.1186","volume":"15","author":[{"given":"K. P.","family":"Jayawickreme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Subasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Weerasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Perera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Dissanayaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,28]]},"reference":[{"issue":"11","key":"2949_CR1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","volume":"56","author":"F Rees","year":"2017","unstructured":"Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology. 2017;56(11):1945\u201361.","journal-title":"Rheumatology"},{"key":"2949_CR2","first-page":"1384","volume":"35","author":"F Davatchi","year":"2008","unstructured":"Davatchi F, Jamshidi A-R, Banihashemi AT, et\u00a0al. WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran. J Rheumatol. 2008;35:1384\u201390.","journal-title":"J Rheumatol"},{"issue":"9","key":"2949_CR3","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et\u00a0al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2949_CR4","first-page":"402","volume":"33","author":"MA Melikoglu","year":"2008","unstructured":"Melikoglu MA, Melikoglu M. The clinical importance of lymphadenopathy in systemic lupus erythematosus. Acta Reumatol Port. 2008;33(4):402\u20136.","journal-title":"Acta Reumatol Port"},{"issue":"1","key":"2949_CR5","first-page":"96","volume":"50","author":"NSR Neto","year":"2010","unstructured":"Neto NSR, Bonfiglioli KR, Milanez FM, de Mac\u00eado PA, Levy-Neto M. Lymphadenopathy and systemic lupus erythematosus. Bras J Rheumatol. 2010;50(1):96-101.e99.","journal-title":"Bras J Rheumatol"},{"issue":"7","key":"2949_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/RHU.0b013e3182a6a924","volume":"19","author":"LW Smith","year":"2013","unstructured":"Smith LW, Gelber AC, Petri M. Diffuse lymphadenopathy as the presenting manifestation of systemic lupus erythematosus. J Clin Rheumatol. 2013;19(7):397\u20139.","journal-title":"J Clin Rheumatol"},{"key":"2949_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1471-2431-13-179","volume":"13","author":"D Shrestha","year":"2013","unstructured":"Shrestha D, Dhakal AK, Shiva RK, Shakya A, Shah SC, Shakya H. Systemic lupus erythematosus and granulomatous lymphadenopathy. BMC Pediatr. 2013;13:179.","journal-title":"BMC Pediatr"},{"key":"2949_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-201802","author":"R Gillmore","year":"2014","unstructured":"Gillmore R, Sin WY. Systemic lupus erythematosus mimicking lymphoma: the relevance of the clinical background in interpreting imaging studies. BMJ Case Rep. 2014. https:\/\/doi.org\/10.1136\/bcr-2013-201802.","journal-title":"BMJ Case Rep"},{"key":"2949_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/BF02230354","volume":"15","author":"Y Shapira","year":"1996","unstructured":"Shapira Y, We\u0131inberger A, Wysenbeek AJ. Lymphadenopathy in systemic lupus erythematosus. Prevalence and relation to disease manifestations. Clin Rheumatol. 1996;15:335\u20138.","journal-title":"Clin Rheumatol"},{"key":"2949_CR10","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1093\/rheumatology\/39.10.1147","volume":"39","author":"SM Sultan","year":"2000","unstructured":"Sultan SM, Ioannou Y, Isenberg DA. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review. Rheumatology (Oxford). 2000;39:1147\u201352.","journal-title":"Rheumatology (Oxford)"},{"key":"2949_CR11","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1136\/ard.2006.067108","volume":"66","author":"B L\u00f6fstr\u00f6m","year":"2007","unstructured":"L\u00f6fstr\u00f6m B, Backlin C, Sundstr\u00f6m C, et\u00a0al. A closer look at non-Hodgkin\u2019s lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study. Ann Rheum Dis. 2007;66:1627\u201332.","journal-title":"Ann Rheum Dis"},{"key":"2949_CR12","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s10067-006-0532-7","volume":"26","author":"JK King","year":"2007","unstructured":"King JK, Costenbader KH. Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkin\u2019s lymphoma (NHL). Clin Rheumatol. 2007;26:1491\u20134.","journal-title":"Clin Rheumatol"},{"key":"2949_CR13","doi-asserted-by":"crossref","unstructured":"G\u0103man M, Vl\u0103d\u0103reanu AM, Dobrea C, Onis\u00e2i M, Marinescu C, Voican I, Vasile D, Bumbea H, C\u00ee\u015fleanu D. A challenging case of Kikuchi-Fujimoto disease associated with systemic lupus erythematosus and review of the literature. Case Rep Hematol. 2018. 1\u20135. Article ID 1791627.","DOI":"10.1155\/2018\/1791627"},{"key":"2949_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2147\/IMCRJ.S106396","volume":"9","author":"DF Baenas","year":"2016","unstructured":"Baenas DF, Diehl FA, Haye Salinas MJ, Riva V, Diller A, Lemos PA. Kikuchi-Fujimoto disease and systemic lupus erythematosus. Int Med Case Rep J. 2016;9:163\u20137.","journal-title":"Int Med Case Rep J"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02949-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-02949-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02949-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T23:04:31Z","timestamp":1624835071000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-02949-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,28]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2949"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-02949-5","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,28]]},"assertion":[{"value":"28 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient gave consent to disclose her information for the case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"328"}}